• Fucoidan Mitigates Irinotecan-Induced Steatohepatitis via Gu

  2026-07-07

  The referenced study uncovers how fucoidan counters irinotecan (CPT-11)-induced steatohepatitis by restoring gut barrier function and suppressing hepatic neutrophil extracellular trap (NET) formation. These findings highlight a mechanistic link between the gut–liver axis, chemotherapy-induced liver injury, and the potential of barrier-targeted interventions for improving cancer therapy tolerance.

• In Vitro Drug Response Metrics: Advances for VEGFR Inhibitor

  2026-07-06

  Schwartz's dissertation fundamentally redefines how in vitro drug responses are evaluated by distinguishing between proliferative arrest and cell death in anti-cancer assays. This methodological advance enables more precise interpretation of agent efficacy in oncology research, such as with VEGFR-targeted inhibitors.

• miR-24-3p/Sp1/PI3K Axis in Doxorubicin-Induced Heart Failure

  2026-07-06

  This study elucidates how miR-24-3p exacerbates cardiac dysfunction in doxorubicin-induced heart failure by directly suppressing the Sp1/PI3K signaling pathway. Silencing miR-24-3p was shown to mitigate apoptosis and oxidative stress, unveiling a new therapeutic target for cardiac injury research.

• Co-Targeting BCL-xL and MCL-1 Induces Lethal Apoptosis in Me

  2026-07-05

  Xu et al. reveal that simultaneous inhibition of anti-apoptotic proteins BCL-xL and MCL-1 triggers rapid, synergistic mitochondrial dysfunction and cell death in diffuse mesothelioma models. The findings clarify the redundancy and compensatory mechanisms of Bcl-2 family proteins, informing safer, more effective strategies for overcoming therapeutic resistance in this aggressive cancer.

• Trelagliptin Succinate: Rethinking Type 2 Diabetes Research

  2026-07-04

  Explore the mechanistic depth and translational promise of Trelagliptin succinate (SYR-472 succinate) as a once-weekly, selective DPP-4 inhibitor. This article advances the scientific dialogue beyond routine product bulletins by integrating validated biological pathways, rigorous analytical standards, and strategic guidance for researchers seeking robust, reproducible results in type 2 diabetes and related metabolic research.

• Strategic Deployment of MK-1775 in Translational Oncology

  2026-07-03

  Explore the mechanistic underpinnings and translational promise of MK-1775 (Wee1 kinase inhibitor) as a catalyst for cell cycle checkpoint abrogation and chemosensitization in p53-deficient cancer research. This thought-leadership article unpacks the latest insights, protocol guidance, and future directions for leveraging APExBIO's MK-1775 in advanced in vitro and in vivo workflows, anchored by emerging doctoral research and comparative literature.

• NF 340: Dissecting P2Y11 Antagonism in Cancer Metastasis Mod

  2026-07-03

  Explore how the P2Y11 antagonist NF 340 enables advanced investigation of purinergic signaling in cancer metastasis. This article delivers a uniquely detailed, evidence-based guide to integrating NF 340 into translational assays, with insights not found in existing content.

• SD 169 (indole-5-carboxamide): Precision p38 MAPK Inhibition

  2026-07-02

  SD 169 (indole-5-carboxamide) enables dual-action, highly selective inhibition of p38α/β MAPK, with quantified efficacy in both type 1 diabetes and neuroregeneration models. Discover stepwise protocols, troubleshooting strategies, and how the latest structural insights empower more reproducible and sensitive kinase pathway modulation.

• Phosbind Acrylamide: Advancing Viral Kinase Phosphorylation

  2026-07-02

  Explore how Phosbind Acrylamide transforms protein phosphorylation analysis in viral kinase research. This article uniquely bridges advanced phosphate-binding reagent workflow with insights from contemporary innate immunity studies.

• Spectral Cytometry Reveals Immune Effects of Ruxolitinib-oHS

  2026-07-01

  This study leverages high-dimensional spectral flow cytometry to characterize immune modulation in murine sarcoma following combined ruxolitinib and oncolytic HSV therapy. The findings reveal expanded CD4+ T cell activity and germinal center B cell populations, underscoring new mechanistic avenues for immunomodulation in myeloproliferative and solid tumor research.

• Fumagillin’s Translational Spectrum: From Angiogenesis to An

  2026-07-01

  Explore Fumagillin as a potent methionine aminopeptidase-2 inhibitor with dual relevance in cancer and antiparasitic research. This deep-dive reveals unique mechanistic insights and practical protocol guidance not found in existing articles.

• SERCA Inhibition by BHQ Enhances HSC Mobilization via ER Str

  2026-06-30

  Li et al. (2025) demonstrate that selective inhibition of SERCA using 2,5-di-tert-butylbenzene-1,4-diol (BHQ) induces mild endoplasmic reticulum (ER) stress, significantly enhancing hematopoietic stem cell (HSC) mobilization in vivo. This mechanistic insight into the CaMKII-STAT3-CXCR4 pathway offers new potential strategies for improving the efficacy of stem cell transplantation.

• Monomethyl Auristatin E (MMAE): Precision Payloads in ADC On

  2026-06-30

  Explore how Monomethyl auristatin E (MMAE) empowers next-generation antibody-drug conjugates (ADCs) with high potency and selectivity for targeted cancer therapy. This deep-dive uniquely examines MMAE’s application in overcoming tumor plasticity and resistance, with practical assay insights for translational oncology.

• Verteporfin (CL 318952): Protocols for Photodynamic and Auto

  2026-06-29

  Verteporfin (CL 318952) stands out as a dual-function tool for precise photodynamic therapy and autophagy inhibition in ocular neovascularization and cell fate studies. This guide delivers protocol-driven insight, practical troubleshooting, and new perspectives for researchers aiming to maximize reproducibility and mechanistic clarity.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Applie

  2026-06-29

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus delivers streamlined, high-yield ARCA-capped mRNA synthesis with polyadenylation—ideal for RNA vaccine development and translational research. This guide highlights experimental workflows, advanced troubleshooting, and protocol enhancements that empower reliable mRNA production for cutting-edge immunotherapy and gene function studies.

15051 records 1/1004 page Next 12345 下5页 Last page